Comparing the current results to its competitors, Nascent Biotech Inc reported Revenue decrease in the 4 quarter 2024 year on year by 0 %, despite the revenue increase by the most of its competitors of 5.84 %, recorded in the same quarter.
Nascent Biotech Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 30.04 %
Nascent Biotech Inc 's Comment on Competition and Industry Peers
The company operates in a competitive environment focused on the development and commercialization of new cancer treatments. It faces competition from major pharmaceutical, biotechnology, and specialty cancer companies, including Ambit Biosciences, Array Biopharma, Genentech, Merk, Roche, and Takeda, which invest substantial resources in research and development. The company is in an early stage with no operational history and has acquired rights to its drug candidates. Competitors often possess greater financial resources, technical expertise, clinical development experience, and capabilities in manufacturing, regulatory affairs, and global commercialization. Additional competition arises from academic institutions, governmental agencies, and private organizations engaged in cancer research. The company seeks to protect its intellectual property through patents and trade secrets but recognizes that such protections may be incomplete or circumvented by competitors.
Sanofi's business model revolves around the development, production, and distribution of pharmaceutical products. They aim to innovate and provide healthcare solutions across various therapeutic areas to improve patients' lives worldwide. Sanofi collaborates with partners and healthcare professionals to ensure effective delivery of their products and to address evolving patient needs.
Biohaven Ltd operates as a pharmaceutical company that focuses on discovering and developing therapies for neurological diseases and rare disorders. Their business model revolves around conducting extensive research and clinical trials to bring innovative treatments to market. By collaborating with healthcare professionals, regulatory agencies, and investors, Biohaven aims to improve the lives of patients suffering from these conditions and provide a significant return on investment for stakeholders.
Legend Biotech Corporation is a biotech company focused on developing innovative cell therapies and gene therapies to address unmet medical needs in various diseases.
TherapeuticsMD Inc is a pharmaceutical company that focuses on developing and commercializing innovative hormone therapy products for women. Their business model revolves around research, development, and marketing of prescription and over-the-counter products catering to women's health needs. By leveraging strategic partnerships and collaborations, they aim to bring their products to market, ultimately improving the quality of life for women.
Eqrx Inc is a pharmaceutical company that focuses on creating affordable and accessible medication. They employ an innovative business model that combines research and development with scientific expertise to develop generic alternatives to the high-priced drugs in the market. By bypassing the traditional pharmaceutical pricing system, Eqrx aims to make essential medications more affordable for patients and healthcare providers.
Sources:
Nascent Biotech Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Nascent Biotech Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
